It’s a busy afternoon in the emergency department when a 3-month-old boy is brought in by his parents.
He’s had three days of fever, cough, and coryzal symptoms. He’s feeding well, alert, and smiling at you — but something doesn’t look right. His lips are tinged blue.
You pop on the pulse oximeter and do a double-take.
Oxygen saturations: 21%.
You check the probe, swap limbs, apply oxygen, change monitors. Still 21%. Yet he’s pink, warm, well perfused and breathing comfortably if not a little upset by all the fuss going on.
What’s going on?
Initial Assessment
- Patent, crying, no stridor
- Mild subcostal recession, equal air entry bilaterally, no wheeze, crackles or crepitations
- Dual heart sounds, no murmurs, strong equal femoral pulses, capillary refill time less than 2 seconds
- Alert and responsive
- Temperature 37.8*C, no rashes or bruising
Pre and post-ductal saturations are identical.ECG shows a normal sinus rhythm.
A venous blood gas shows pH 7.42, a lactate of 1.8, and no metabolic acidosis.
The monitor says profound hypoxia. But the examination and investigations scream the baby is fine.
When the Numbers Don’t Match the Child
Whenever a child looks better than their monitor readings, it’s time to pause and think.
Differentials for apparent hypoxia include:
- Poor probe placement or motion artefact
- Congenital heart disease (normal serial examinations and ECG)
- Pulmonary pathology (normal examinations)
- Methaemoglobinaemia — congenital or acquired
Then comes the key clue. Mum casually mentions she has a blood condition, diagnosed years ago after a similar scare. Her lips are also slightly blue, and her saturations are checked, showing 31%.
Diagnosis
Given the reassuring clinical picture, relevant family history, and absence of recent exposure to oxidising agents associated with acquired methaemoglobinaemia (such as nitrites or dapsone, or—particularly in the paediatric setting—prolonged use of topical anaesthetic agents including bupivacaine, lidocaine, and prilocaine), congenital methaemoglobinaemia is suspected.
The boy is admitted for observation and remains stable throughout.
Outpatient testing later confirmed a methaemoglobin level of 13.6%, with further analysis confirming the HbM Saskatoon Variant.
Congenital Methaemoglobinaemia: Two Distinct Mechanisms
Congenital methaemoglobinaemia isn’t a single condition — it arises from two main mechanisms, each with its own inheritance pattern and clinical course.
Autosomal Recessive: NADH–Cytochrome B5 Reductase Deficiency
This enzyme normally reduces ferric (Fe³⁺) haemoglobin back to its oxygen-carrying ferrous (Fe²⁺) state.
Deficiency causes chronic low-level methaemoglobinaemia, with two recognised types:
- Type I (erythrocyte-limited): lifelong cyanosis but otherwise well
- Type II (generalised): severe neurodevelopmental delay and early mortality
Parents are typically asymptomatic carriers; therefore, family history may be unremarkable.
Autosomal Dominant: Haemoglobin M Variants
Here, a structural mutation in the globin chain (α, β, or γ) locks iron in the ferric form, resistant to enzymatic reduction.
These variants are inherited in an autosomal-dominant pattern and typically cause lifelong cyanosis without systemic compromise.
Why the Pulse Oximeter Lies
Pulse oximetry estimates oxygen saturation by measuring light absorption at two wavelengths (660 nm and 940 nm). Methaemoglobin absorbs both equally, confusing the algorithm and producing low readings.
True oxygenation can only be assessed by co-oximetry.
What is Co-oximetry?
Co-oximetry is a method for measuring the different types of haemoglobin in the blood, not only oxygenated and deoxygenated haemoglobin (as a standard pulse oximeter does), but also dysfunctional forms such as methemoglobin and carboxyhaemoglobin.
A pulse oximeter uses two wavelengths of light (red and infrared) to estimate oxygen saturation, assuming all haemoglobin is either oxygenated (HbO₂) or deoxygenated (Hb).
A co-oximeter, by contrast, uses multiple wavelengths (usually four or more) to directly measure the amount of light absorbed by each distinct change in haemoglobin.
That means co-oximetry can tell you:
- The fraction of methaemoglobin (%MetHb),
- The fraction of carboxyhaemoglobin (%COHb),
- The true oxygen saturation (SaO₂) based on how much haemoglobin is actually capable of carrying oxygen.
- Normal methaemoglobin levels are typically <1–2%.
- Levels above that indicate methaemoglobinaemia.
- A normal PaO₂ (partial pressure of oxygen) alongside low SpO₂ but high functional saturation on co-oximetry suggests the apparent “hypoxia” is artefactual.
- Conversely, elevated %MetHb confirms true methaemoglobinaemia.
In short, co-oximetry tells you the truth when the pulse oximeter lies.
Managing Respiratory Illness in These Patients
Respiratory infections are common in infancy, and cyanosis often prompts escalation. But in children with congenital methaemoglobinaemia, this can lead to over-treatment if the diagnosis is missed.
The key challenge is interpreting oxygenation accurately when standard pulse oximetry is unreliable.
Instead, clinicians should focus on:
- Clinical examination: look for increased work of breathing, tachypnoea, or poor feeding.
- Perfusion markers: capillary refill, heart rate, and mental state are far more informative than SpO₂ values.
- Blood lactate: A normal lactate level reassures that tissue oxygen delivery remains adequate.
- Co-oximetry, when available, directly measures functional haemoglobin species and confirms true oxygen saturation.
During intercurrent illness, supportive care and close observation are usually all that’s required.
Oxygen therapy can be offered for comfort, but it will not normalise saturations in HbM variants and methylene blue should be avoided, as it’s ineffective with potentially harmful side effects.
Why No Methylene Blue in Congenital Methaemoglobinaemia?
It’s tempting to reach for methylene blue when you see low saturations — after all, it’s the recognised antidote for acquired methaemoglobinaemia (from drugs like nitrates, dapsone, or local anaesthetics).
However, in congenital forms—particularly Haemoglobin M variants—it doesn’t work.
Why is it ineffective?
Methylene blue acts as an artificial electron carrier. In acquired methaemoglobinaemia, it uses the NADPH–methemoglobin reductase pathway to convert ferric iron (Fe³⁺) in methaemoglobin back to its normal ferrous (Fe²⁺) state, restoring oxygen-carrying capacity.
However, in congenital methaemoglobinaemia due to Haemoglobin M:
- The problem isn’t the enzyme — it’s the structure of the haemoglobin molecule itself.
- The iron is locked in the ferric state by a globin chain mutation, rendering it resistant to reduction.
- Giving methylene blue won’t change this chemistry — so it won’t “fix” the cyanosis or the SpO₂. In fact, it can make things worse.
Potential harms
Methylene blue is not harmless. Its use in infants and young children carries additional risks:
- Haemolysis — particularly in those with G6PD deficiency, where red cells can’t handle the oxidative stress.
- Paradoxical methaemoglobinaemia — at high doses, methylene blue can actually oxidise haemoglobin further.
- Serotonin toxicity — Methylene blue is a potent MAO inhibitor and can precipitate serotonin syndrome if the patient is on serotonergic medications.
- Other adverse effects include hypotension, nausea, vomiting, chest pain, and discolouration of the skin, urine, and mucous membranes.
Key Takeaways
This case illustrates why you should treat the child, not the numbers. Our patient’s SpO₂ read 21%, yet he was pink, alert, and well-perfused. Normal lactate confirmed adequate tissue oxygenation.
When numbers don’t make sense, return to the fundamentals:
- Look at the child’s colour, tone, effort, and activity.
- Feel for pulses and check capillary refill.
- Use lactate and co-oximetry to guide you if concerned.
Recognising congenital causes of cyanosis prevents unnecessary escalation, invasive testing, and inappropriate treatments.
